शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
Companies›Healthcare›Healthcare›Pharmaceuticals & Biotechnology

KERALA AYURVEDA LTD.

Healthcare › Pharmaceuticals & Biotechnology
₹143.70
at close · 6 Nov 2026
▼ 5.25 (-3.52%)

Latest filings

  1. Board to approve September quarter and half-year results · Results
  2. Kerala Ayurveda allots 6,55,000 shares to promoter group at Rs 190.37 · Fund Raising
  3. Compliance certificate for dematerialization of securities for Q2 FY27 · Compliance
All filings ↓
Ask Nexa about KERALA AYURVEDA LTD.

Snapshot

What the business is, and whether it's a good one at a fair price.

A Pharmaceuticals & Biotechnology company listed on BSE, reporting revenue of ₹136 Cr over the trailing twelve months.

Market Cap
₹193 Cr
P / E (TTM)
—
EV / EBITDA
—
Div Yield
—
Growth
17.3%▲
Revenue 5y CAGR
PAT — · EBITDA —
Quality
5.7%·
ROCE (5y median)
ROE -5.4% (5y median) · margin -13.5%
Leverage
5.43·
Debt / Equity · high
Net debt ₹75 Cr
Revenue FY21→FY26
2.2×▲
Margin −4.2 pts
₹59 Cr → ₹131 Cr
Moves on a normal day
1.85%·
Median daily move
Last 268 sessions · the yardstick for filing-day moves
Where it sits among 185 Pharmaceuticals peersBar = share of peers beaten · tick = industry median · latest reported figures
P/B#152/163
ROCE#170/177
ROE#165/165
Debt / Equity#166/166
EBITDA margin#161/178
Revenue growth#85/163
Profit growth#156/157

Scorecard

Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice

Strengths
Revenue compounding 17% a year over 5 years
Concerns
Erratic profits — up in only 1 of the last 5 years
Returns on capital 5.7% (5-year median)
#170 of 177 in Pharmaceuticals on the latest reported figures · down from −0.5% in FY21
Carries more debt than its peers — 5.43× equity
higher than 100% of its 166 Pharmaceuticals peers

Charts

How has the market priced it — with filings on the timeline?

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from KERALA AYURVEDA LTD.'s filed financials and exchange disclosures

What does KERALA AYURVEDA LTD. do?

KERALA AYURVEDA LTD. is a Pharmaceuticals & Biotechnology company listed on BSE.

Is KERALA AYURVEDA LTD. profitable?

No. Over the trailing twelve months KERALA AYURVEDA LTD. reported a net loss of ₹26 Cr on revenue of ₹136 Cr.

Does KERALA AYURVEDA LTD. pay a dividend?

Not in the latest reported year — KERALA AYURVEDA LTD.'s dividend payout for FY26 was nil.

Is KERALA AYURVEDA LTD. debt-free?

No. It reported borrowings of ₹81 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹75 Cr after cash. Debt stands at 5.43× equity. That is higher than 100% of its 166 Pharmaceuticals peers.

How much does the KERALA AYURVEDA LTD. share price move in a day?

On a typical session KERALA AYURVEDA LTD. moves 1.85% — that is the median absolute close-to-close move across its last 268 trading days. MarketPing measures each filing's price reaction against it.

Where can I track KERALA AYURVEDA LTD.'s announcements?

Every NSE and BSE filing by KERALA AYURVEDA LTD. appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.